The combined results showed that there was higher expression of CEP55 mRNA in adrenocortical carcinoma (ACC), BLCA, BRCA, CESC, COAD, DLBC, GBM, HNSC, KIRC, LUAD, LUSC, ovarian serous cystadenocarcinoma (OV), PAAD, READ, SKCM, STAD, THYM, UCEC, and uterine carcinosarcoma (UCS), but lower levels in acute myeloid leukemia (LAML) (Figure 1C,D). This evidence concerns the gene CEP55 and ovarian serous cystadenocarcinoma.